Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K

about

Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K

Item

http://www.wikidata.org/entity/Q35854453

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Occult oncocytic papillary thy ...... ations of BRAF V600E and V600K

@ast

Occult oncocytic papillary thy ...... ations of BRAF V600E and V600K

@en

type

Item

label

Occult oncocytic papillary thy ...... ations of BRAF V600E and V600K

@ast

Occult oncocytic papillary thy ...... ations of BRAF V600E and V600K

@en

prefLabel

Occult oncocytic papillary thy ...... ations of BRAF V600E and V600K

@ast

Occult oncocytic papillary thy ...... ations of BRAF V600E and V600K

@en

P1476

Occult oncocytic papillary thy ...... ations of BRAF V600E and V600K

@en

P2093

Fei Han

http://www.w3.org/2001/XMLSchema#string

Hong Zhou

http://www.w3.org/2001/XMLSchema#string

Long Zhang

http://www.w3.org/2001/XMLSchema#string

Suxia Zhang

http://www.w3.org/2001/XMLSchema#string

Xianghua Yi

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.

Warthin-like tumor variant of papillary thyroid carcinoma: case report and literature review.

Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.

Warthin-like tumor of the thyroid gland: an uncommon variant of papillary thyroid cancer.

The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.

Warthin-like papillary carcinoma of the thyroid: a case series and review of the literature.

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

Oncocytic papillary carcinoma with lymphoid stroma (Warthin-like tumour) of the thyroid: a distinct entity with favourable prognosis.

Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.

P304

5896-5901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26191315

http://www.w3.org/2001/XMLSchema#string

P932

4503186

http://www.w3.org/2001/XMLSchema#string